Pick #7: InSight (biotech) — earnings and pipeline

Steven Cress highlights InSight's positive earnings, diverse therapy pipeline and outsized EPS and PEG advantages.

Play episode from 32:01

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!